INFLAMMATORY BOWEL DISEASES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2204749, encodeId=0b212204e49e5, content=投稿一天多从submitted 变成under review，目前投稿500出头，从IBD-s-24-670+变成IBD-d-24-520+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 15 03:20:57 CST 2024, time=2024-05-15, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2123385, encodeId=b4d9212338547, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2023年1月10投稿，投稿后立马under review，期间就更新过两次状态，最近一次更新是2月15号，到现在一直没有更新，已经快三个样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Mon Apr 03 10:29:55 CST 2023, time=2023-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1238026, encodeId=fb7612380266a, content=真无语啊，提供的官方链接都是错误的，我死也打不开。 这里才是 https://academic.oup.com/journals/pages/authors, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cee5422993, createdName=ms6000001789977492, createdTime=Thu Aug 11 10:15:49 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232377, encodeId=917512323e787, content=一个半月啦，还在under review，其中under review的时间变了5次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:14:58 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070890, encodeId=fbf510e089010, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：Aug 27 2021 Submitted to journal Aug 30 2021 With Editor Sep 5 2021 With Editor Sep 7 2021 Under Review Sep 13 2021 Under Review Sep 16 2021 Under Review Sep 22 2021 Under Review Sep 22 2021 Under Review Oct 19 2021 Revise Oct 29 2021 Submitted to journal Nov 1 2021 With Editor Nov 2 2021 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8a762575436, createdName=12591279m60暂无昵称, createdTime=Tue Nov 16 21:08:05 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214423, encodeId=02ea121442326, content=审稿速度:3.0 偏重的研究方向：基础;炎症性肠病 经验分享：IBD这个杂志比较坑，最近我们投了一篇，炎症性肠病的基础研究。21年七月份投到，witheditor一个月，under review两个月也就是十月中下旬了，大修返回去又花费了两个月，reviewer满意了回复，然后编辑说图片分辨率不行小修，小修后返回去了，又说语言的问题，历经差不多一年，今年四月份了，以语言的问题拒稿重投，后来又重新投了，10天左右直接拒稿，感觉被杂志耍了，差不多浪费了一年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150810/IMG55C7E7216F9045349.jpg, createdBy=8eec1605831, createdName=shanpingwang, createdTime=Tue Apr 26 11:05:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192388, encodeId=c2821192388e2, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>最近是杂志官网有问题吗？投稿链接进不去呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef215552331, createdName=ms9000001801623307, createdTime=Fri Feb 11 17:08:10 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580933, encodeId=072e580933dc, content=您好，我想问一下您是在哪里看到的投稿要求呢？132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=baef5240403, createdName=147bcb10m39暂无昵称, createdTime=Wed Dec 04 00:00:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091902, encodeId=75de109190256, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091901, encodeId=e48d109190174, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2024-05-15 ms2000000536781631 来自甘肃省

投稿一天多从submitted 变成under review，目前投稿500出头，从IBD-s-24-670+变成IBD-d-24-520+

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204749, encodeId=0b212204e49e5, content=投稿一天多从submitted 变成under review，目前投稿500出头，从IBD-s-24-670+变成IBD-d-24-520+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 15 03:20:57 CST 2024, time=2024-05-15, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2123385, encodeId=b4d9212338547, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2023年1月10投稿，投稿后立马under review，期间就更新过两次状态，最近一次更新是2月15号，到现在一直没有更新，已经快三个样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Mon Apr 03 10:29:55 CST 2023, time=2023-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1238026, encodeId=fb7612380266a, content=真无语啊，提供的官方链接都是错误的，我死也打不开。 这里才是 https://academic.oup.com/journals/pages/authors, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cee5422993, createdName=ms6000001789977492, createdTime=Thu Aug 11 10:15:49 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232377, encodeId=917512323e787, content=一个半月啦，还在under review，其中under review的时间变了5次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:14:58 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070890, encodeId=fbf510e089010, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：Aug 27 2021 Submitted to journal Aug 30 2021 With Editor Sep 5 2021 With Editor Sep 7 2021 Under Review Sep 13 2021 Under Review Sep 16 2021 Under Review Sep 22 2021 Under Review Sep 22 2021 Under Review Oct 19 2021 Revise Oct 29 2021 Submitted to journal Nov 1 2021 With Editor Nov 2 2021 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8a762575436, createdName=12591279m60暂无昵称, createdTime=Tue Nov 16 21:08:05 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214423, encodeId=02ea121442326, content=审稿速度:3.0 偏重的研究方向：基础;炎症性肠病 经验分享：IBD这个杂志比较坑，最近我们投了一篇，炎症性肠病的基础研究。21年七月份投到，witheditor一个月，under review两个月也就是十月中下旬了，大修返回去又花费了两个月，reviewer满意了回复，然后编辑说图片分辨率不行小修，小修后返回去了，又说语言的问题，历经差不多一年，今年四月份了，以语言的问题拒稿重投，后来又重新投了，10天左右直接拒稿，感觉被杂志耍了，差不多浪费了一年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150810/IMG55C7E7216F9045349.jpg, createdBy=8eec1605831, createdName=shanpingwang, createdTime=Tue Apr 26 11:05:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192388, encodeId=c2821192388e2, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>最近是杂志官网有问题吗？投稿链接进不去呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef215552331, createdName=ms9000001801623307, createdTime=Fri Feb 11 17:08:10 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580933, encodeId=072e580933dc, content=您好，我想问一下您是在哪里看到的投稿要求呢？132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=baef5240403, createdName=147bcb10m39暂无昵称, createdTime=Wed Dec 04 00:00:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091902, encodeId=75de109190256, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091901, encodeId=e48d109190174, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-04-03 758880040 来自江苏省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：2023年1月10投稿，投稿后立马under review，期间就更新过两次状态，最近一次更新是2月15号，到现在一直没有更新，已经快三个样了

78 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204749, encodeId=0b212204e49e5, content=投稿一天多从submitted 变成under review，目前投稿500出头，从IBD-s-24-670+变成IBD-d-24-520+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 15 03:20:57 CST 2024, time=2024-05-15, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2123385, encodeId=b4d9212338547, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2023年1月10投稿，投稿后立马under review，期间就更新过两次状态，最近一次更新是2月15号，到现在一直没有更新，已经快三个样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Mon Apr 03 10:29:55 CST 2023, time=2023-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1238026, encodeId=fb7612380266a, content=真无语啊，提供的官方链接都是错误的，我死也打不开。 这里才是 https://academic.oup.com/journals/pages/authors, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cee5422993, createdName=ms6000001789977492, createdTime=Thu Aug 11 10:15:49 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232377, encodeId=917512323e787, content=一个半月啦，还在under review，其中under review的时间变了5次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:14:58 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070890, encodeId=fbf510e089010, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：Aug 27 2021 Submitted to journal Aug 30 2021 With Editor Sep 5 2021 With Editor Sep 7 2021 Under Review Sep 13 2021 Under Review Sep 16 2021 Under Review Sep 22 2021 Under Review Sep 22 2021 Under Review Oct 19 2021 Revise Oct 29 2021 Submitted to journal Nov 1 2021 With Editor Nov 2 2021 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8a762575436, createdName=12591279m60暂无昵称, createdTime=Tue Nov 16 21:08:05 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214423, encodeId=02ea121442326, content=审稿速度:3.0 偏重的研究方向：基础;炎症性肠病 经验分享：IBD这个杂志比较坑，最近我们投了一篇，炎症性肠病的基础研究。21年七月份投到，witheditor一个月，under review两个月也就是十月中下旬了，大修返回去又花费了两个月，reviewer满意了回复，然后编辑说图片分辨率不行小修，小修后返回去了，又说语言的问题，历经差不多一年，今年四月份了，以语言的问题拒稿重投，后来又重新投了，10天左右直接拒稿，感觉被杂志耍了，差不多浪费了一年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150810/IMG55C7E7216F9045349.jpg, createdBy=8eec1605831, createdName=shanpingwang, createdTime=Tue Apr 26 11:05:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192388, encodeId=c2821192388e2, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>最近是杂志官网有问题吗？投稿链接进不去呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef215552331, createdName=ms9000001801623307, createdTime=Fri Feb 11 17:08:10 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580933, encodeId=072e580933dc, content=您好，我想问一下您是在哪里看到的投稿要求呢？132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=baef5240403, createdName=147bcb10m39暂无昵称, createdTime=Wed Dec 04 00:00:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091902, encodeId=75de109190256, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091901, encodeId=e48d109190174, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-08-11 ms6000001789977492

真无语啊，提供的官方链接都是错误的，我死也打不开。
这里才是 https://academic.oup.com/journals/pages/authors

118 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204749, encodeId=0b212204e49e5, content=投稿一天多从submitted 变成under review，目前投稿500出头，从IBD-s-24-670+变成IBD-d-24-520+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 15 03:20:57 CST 2024, time=2024-05-15, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2123385, encodeId=b4d9212338547, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2023年1月10投稿，投稿后立马under review，期间就更新过两次状态，最近一次更新是2月15号，到现在一直没有更新，已经快三个样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Mon Apr 03 10:29:55 CST 2023, time=2023-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1238026, encodeId=fb7612380266a, content=真无语啊，提供的官方链接都是错误的，我死也打不开。 这里才是 https://academic.oup.com/journals/pages/authors, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cee5422993, createdName=ms6000001789977492, createdTime=Thu Aug 11 10:15:49 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232377, encodeId=917512323e787, content=一个半月啦，还在under review，其中under review的时间变了5次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:14:58 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070890, encodeId=fbf510e089010, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：Aug 27 2021 Submitted to journal Aug 30 2021 With Editor Sep 5 2021 With Editor Sep 7 2021 Under Review Sep 13 2021 Under Review Sep 16 2021 Under Review Sep 22 2021 Under Review Sep 22 2021 Under Review Oct 19 2021 Revise Oct 29 2021 Submitted to journal Nov 1 2021 With Editor Nov 2 2021 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8a762575436, createdName=12591279m60暂无昵称, createdTime=Tue Nov 16 21:08:05 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214423, encodeId=02ea121442326, content=审稿速度:3.0 偏重的研究方向：基础;炎症性肠病 经验分享：IBD这个杂志比较坑，最近我们投了一篇，炎症性肠病的基础研究。21年七月份投到，witheditor一个月，under review两个月也就是十月中下旬了，大修返回去又花费了两个月，reviewer满意了回复，然后编辑说图片分辨率不行小修，小修后返回去了，又说语言的问题，历经差不多一年，今年四月份了，以语言的问题拒稿重投，后来又重新投了，10天左右直接拒稿，感觉被杂志耍了，差不多浪费了一年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150810/IMG55C7E7216F9045349.jpg, createdBy=8eec1605831, createdName=shanpingwang, createdTime=Tue Apr 26 11:05:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192388, encodeId=c2821192388e2, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>最近是杂志官网有问题吗？投稿链接进不去呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef215552331, createdName=ms9000001801623307, createdTime=Fri Feb 11 17:08:10 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580933, encodeId=072e580933dc, content=您好，我想问一下您是在哪里看到的投稿要求呢？132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=baef5240403, createdName=147bcb10m39暂无昵称, createdTime=Wed Dec 04 00:00:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091902, encodeId=75de109190256, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091901, encodeId=e48d109190174, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-07-14 krygios

一个半月啦，还在under review，其中under review的时间变了5次

132 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204749, encodeId=0b212204e49e5, content=投稿一天多从submitted 变成under review，目前投稿500出头，从IBD-s-24-670+变成IBD-d-24-520+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 15 03:20:57 CST 2024, time=2024-05-15, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2123385, encodeId=b4d9212338547, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2023年1月10投稿，投稿后立马under review，期间就更新过两次状态，最近一次更新是2月15号，到现在一直没有更新，已经快三个样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Mon Apr 03 10:29:55 CST 2023, time=2023-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1238026, encodeId=fb7612380266a, content=真无语啊，提供的官方链接都是错误的，我死也打不开。 这里才是 https://academic.oup.com/journals/pages/authors, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cee5422993, createdName=ms6000001789977492, createdTime=Thu Aug 11 10:15:49 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232377, encodeId=917512323e787, content=一个半月啦，还在under review，其中under review的时间变了5次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:14:58 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070890, encodeId=fbf510e089010, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：Aug 27 2021 Submitted to journal Aug 30 2021 With Editor Sep 5 2021 With Editor Sep 7 2021 Under Review Sep 13 2021 Under Review Sep 16 2021 Under Review Sep 22 2021 Under Review Sep 22 2021 Under Review Oct 19 2021 Revise Oct 29 2021 Submitted to journal Nov 1 2021 With Editor Nov 2 2021 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8a762575436, createdName=12591279m60暂无昵称, createdTime=Tue Nov 16 21:08:05 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214423, encodeId=02ea121442326, content=审稿速度:3.0 偏重的研究方向：基础;炎症性肠病 经验分享：IBD这个杂志比较坑，最近我们投了一篇，炎症性肠病的基础研究。21年七月份投到，witheditor一个月，under review两个月也就是十月中下旬了，大修返回去又花费了两个月，reviewer满意了回复，然后编辑说图片分辨率不行小修，小修后返回去了，又说语言的问题，历经差不多一年，今年四月份了，以语言的问题拒稿重投，后来又重新投了，10天左右直接拒稿，感觉被杂志耍了，差不多浪费了一年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150810/IMG55C7E7216F9045349.jpg, createdBy=8eec1605831, createdName=shanpingwang, createdTime=Tue Apr 26 11:05:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192388, encodeId=c2821192388e2, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>最近是杂志官网有问题吗？投稿链接进不去呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef215552331, createdName=ms9000001801623307, createdTime=Fri Feb 11 17:08:10 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580933, encodeId=072e580933dc, content=您好，我想问一下您是在哪里看到的投稿要求呢？132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=baef5240403, createdName=147bcb10m39暂无昵称, createdTime=Wed Dec 04 00:00:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091902, encodeId=75de109190256, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091901, encodeId=e48d109190174, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-11-16 12591279m60暂无昵称

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：炎症性肠病
经验分享：Aug 27 2021 Submitted to journal Aug 30 2021 With Editor Sep 5 2021 With Editor Sep 7 2021 Under Review Sep 13 2021 Under Review Sep 16 2021 Under Review Sep 22 2021 Under Review Sep 22 2021 Under Review Oct 19 2021 Revise Oct 29 2021 Submitted to journal Nov 1 2021 With Editor Nov 2 2021 Accept

289 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204749, encodeId=0b212204e49e5, content=投稿一天多从submitted 变成under review，目前投稿500出头，从IBD-s-24-670+变成IBD-d-24-520+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 15 03:20:57 CST 2024, time=2024-05-15, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2123385, encodeId=b4d9212338547, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2023年1月10投稿，投稿后立马under review，期间就更新过两次状态，最近一次更新是2月15号，到现在一直没有更新，已经快三个样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Mon Apr 03 10:29:55 CST 2023, time=2023-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1238026, encodeId=fb7612380266a, content=真无语啊，提供的官方链接都是错误的，我死也打不开。 这里才是 https://academic.oup.com/journals/pages/authors, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cee5422993, createdName=ms6000001789977492, createdTime=Thu Aug 11 10:15:49 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232377, encodeId=917512323e787, content=一个半月啦，还在under review，其中under review的时间变了5次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:14:58 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070890, encodeId=fbf510e089010, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：Aug 27 2021 Submitted to journal Aug 30 2021 With Editor Sep 5 2021 With Editor Sep 7 2021 Under Review Sep 13 2021 Under Review Sep 16 2021 Under Review Sep 22 2021 Under Review Sep 22 2021 Under Review Oct 19 2021 Revise Oct 29 2021 Submitted to journal Nov 1 2021 With Editor Nov 2 2021 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8a762575436, createdName=12591279m60暂无昵称, createdTime=Tue Nov 16 21:08:05 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214423, encodeId=02ea121442326, content=审稿速度:3.0 偏重的研究方向：基础;炎症性肠病 经验分享：IBD这个杂志比较坑，最近我们投了一篇，炎症性肠病的基础研究。21年七月份投到，witheditor一个月，under review两个月也就是十月中下旬了，大修返回去又花费了两个月，reviewer满意了回复，然后编辑说图片分辨率不行小修，小修后返回去了，又说语言的问题，历经差不多一年，今年四月份了，以语言的问题拒稿重投，后来又重新投了，10天左右直接拒稿，感觉被杂志耍了，差不多浪费了一年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150810/IMG55C7E7216F9045349.jpg, createdBy=8eec1605831, createdName=shanpingwang, createdTime=Tue Apr 26 11:05:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192388, encodeId=c2821192388e2, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>最近是杂志官网有问题吗？投稿链接进不去呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef215552331, createdName=ms9000001801623307, createdTime=Fri Feb 11 17:08:10 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580933, encodeId=072e580933dc, content=您好，我想问一下您是在哪里看到的投稿要求呢？132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=baef5240403, createdName=147bcb10m39暂无昵称, createdTime=Wed Dec 04 00:00:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091902, encodeId=75de109190256, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091901, encodeId=e48d109190174, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-04-26 shanpingwang

审稿速度:3.0
偏重的研究方向：基础;炎症性肠病
经验分享：IBD这个杂志比较坑，最近我们投了一篇，炎症性肠病的基础研究。21年七月份投到，witheditor一个月，under review两个月也就是十月中下旬了，大修返回去又花费了两个月，reviewer满意了回复，然后编辑说图片分辨率不行小修，小修后返回去了，又说语言的问题，历经差不多一年，今年四月份了，以语言的问题拒稿重投，后来又重新投了，10天左右直接拒稿，感觉被杂志耍了，差不多浪费了一年时间

170 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204749, encodeId=0b212204e49e5, content=投稿一天多从submitted 变成under review，目前投稿500出头，从IBD-s-24-670+变成IBD-d-24-520+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 15 03:20:57 CST 2024, time=2024-05-15, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2123385, encodeId=b4d9212338547, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2023年1月10投稿，投稿后立马under review，期间就更新过两次状态，最近一次更新是2月15号，到现在一直没有更新，已经快三个样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Mon Apr 03 10:29:55 CST 2023, time=2023-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1238026, encodeId=fb7612380266a, content=真无语啊，提供的官方链接都是错误的，我死也打不开。 这里才是 https://academic.oup.com/journals/pages/authors, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cee5422993, createdName=ms6000001789977492, createdTime=Thu Aug 11 10:15:49 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232377, encodeId=917512323e787, content=一个半月啦，还在under review，其中under review的时间变了5次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:14:58 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070890, encodeId=fbf510e089010, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：Aug 27 2021 Submitted to journal Aug 30 2021 With Editor Sep 5 2021 With Editor Sep 7 2021 Under Review Sep 13 2021 Under Review Sep 16 2021 Under Review Sep 22 2021 Under Review Sep 22 2021 Under Review Oct 19 2021 Revise Oct 29 2021 Submitted to journal Nov 1 2021 With Editor Nov 2 2021 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8a762575436, createdName=12591279m60暂无昵称, createdTime=Tue Nov 16 21:08:05 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214423, encodeId=02ea121442326, content=审稿速度:3.0 偏重的研究方向：基础;炎症性肠病 经验分享：IBD这个杂志比较坑，最近我们投了一篇，炎症性肠病的基础研究。21年七月份投到，witheditor一个月，under review两个月也就是十月中下旬了，大修返回去又花费了两个月，reviewer满意了回复，然后编辑说图片分辨率不行小修，小修后返回去了，又说语言的问题，历经差不多一年，今年四月份了，以语言的问题拒稿重投，后来又重新投了，10天左右直接拒稿，感觉被杂志耍了，差不多浪费了一年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150810/IMG55C7E7216F9045349.jpg, createdBy=8eec1605831, createdName=shanpingwang, createdTime=Tue Apr 26 11:05:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192388, encodeId=c2821192388e2, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>最近是杂志官网有问题吗？投稿链接进不去呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef215552331, createdName=ms9000001801623307, createdTime=Fri Feb 11 17:08:10 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580933, encodeId=072e580933dc, content=您好，我想问一下您是在哪里看到的投稿要求呢？132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=baef5240403, createdName=147bcb10m39暂无昵称, createdTime=Wed Dec 04 00:00:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091902, encodeId=75de109190256, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091901, encodeId=e48d109190174, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-02-11 ms9000001801623307

#期刊论坛#最近是杂志官网有问题吗？投稿链接进不去呀？

306 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204749, encodeId=0b212204e49e5, content=投稿一天多从submitted 变成under review，目前投稿500出头，从IBD-s-24-670+变成IBD-d-24-520+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 15 03:20:57 CST 2024, time=2024-05-15, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2123385, encodeId=b4d9212338547, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2023年1月10投稿，投稿后立马under review，期间就更新过两次状态，最近一次更新是2月15号，到现在一直没有更新，已经快三个样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Mon Apr 03 10:29:55 CST 2023, time=2023-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1238026, encodeId=fb7612380266a, content=真无语啊，提供的官方链接都是错误的，我死也打不开。 这里才是 https://academic.oup.com/journals/pages/authors, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cee5422993, createdName=ms6000001789977492, createdTime=Thu Aug 11 10:15:49 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232377, encodeId=917512323e787, content=一个半月啦，还在under review，其中under review的时间变了5次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:14:58 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070890, encodeId=fbf510e089010, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：Aug 27 2021 Submitted to journal Aug 30 2021 With Editor Sep 5 2021 With Editor Sep 7 2021 Under Review Sep 13 2021 Under Review Sep 16 2021 Under Review Sep 22 2021 Under Review Sep 22 2021 Under Review Oct 19 2021 Revise Oct 29 2021 Submitted to journal Nov 1 2021 With Editor Nov 2 2021 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8a762575436, createdName=12591279m60暂无昵称, createdTime=Tue Nov 16 21:08:05 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214423, encodeId=02ea121442326, content=审稿速度:3.0 偏重的研究方向：基础;炎症性肠病 经验分享：IBD这个杂志比较坑，最近我们投了一篇，炎症性肠病的基础研究。21年七月份投到，witheditor一个月，under review两个月也就是十月中下旬了，大修返回去又花费了两个月，reviewer满意了回复，然后编辑说图片分辨率不行小修，小修后返回去了，又说语言的问题，历经差不多一年，今年四月份了，以语言的问题拒稿重投，后来又重新投了，10天左右直接拒稿，感觉被杂志耍了，差不多浪费了一年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150810/IMG55C7E7216F9045349.jpg, createdBy=8eec1605831, createdName=shanpingwang, createdTime=Tue Apr 26 11:05:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192388, encodeId=c2821192388e2, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>最近是杂志官网有问题吗？投稿链接进不去呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef215552331, createdName=ms9000001801623307, createdTime=Fri Feb 11 17:08:10 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580933, encodeId=072e580933dc, content=您好，我想问一下您是在哪里看到的投稿要求呢？132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=baef5240403, createdName=147bcb10m39暂无昵称, createdTime=Wed Dec 04 00:00:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091902, encodeId=75de109190256, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091901, encodeId=e48d109190174, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2019-12-04 147bcb10m39暂无昵称

您好，我想问一下您是在哪里看到的投稿要求呢？132****5832暂无昵称 2019-10-25 00:00:00 发表:
有点时间长了

132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了

329 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204749, encodeId=0b212204e49e5, content=投稿一天多从submitted 变成under review，目前投稿500出头，从IBD-s-24-670+变成IBD-d-24-520+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 15 03:20:57 CST 2024, time=2024-05-15, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2123385, encodeId=b4d9212338547, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2023年1月10投稿，投稿后立马under review，期间就更新过两次状态，最近一次更新是2月15号，到现在一直没有更新，已经快三个样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Mon Apr 03 10:29:55 CST 2023, time=2023-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1238026, encodeId=fb7612380266a, content=真无语啊，提供的官方链接都是错误的，我死也打不开。 这里才是 https://academic.oup.com/journals/pages/authors, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cee5422993, createdName=ms6000001789977492, createdTime=Thu Aug 11 10:15:49 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232377, encodeId=917512323e787, content=一个半月啦，还在under review，其中under review的时间变了5次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:14:58 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070890, encodeId=fbf510e089010, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：Aug 27 2021 Submitted to journal Aug 30 2021 With Editor Sep 5 2021 With Editor Sep 7 2021 Under Review Sep 13 2021 Under Review Sep 16 2021 Under Review Sep 22 2021 Under Review Sep 22 2021 Under Review Oct 19 2021 Revise Oct 29 2021 Submitted to journal Nov 1 2021 With Editor Nov 2 2021 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8a762575436, createdName=12591279m60暂无昵称, createdTime=Tue Nov 16 21:08:05 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214423, encodeId=02ea121442326, content=审稿速度:3.0 偏重的研究方向：基础;炎症性肠病 经验分享：IBD这个杂志比较坑，最近我们投了一篇，炎症性肠病的基础研究。21年七月份投到，witheditor一个月，under review两个月也就是十月中下旬了，大修返回去又花费了两个月，reviewer满意了回复，然后编辑说图片分辨率不行小修，小修后返回去了，又说语言的问题，历经差不多一年，今年四月份了，以语言的问题拒稿重投，后来又重新投了，10天左右直接拒稿，感觉被杂志耍了，差不多浪费了一年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150810/IMG55C7E7216F9045349.jpg, createdBy=8eec1605831, createdName=shanpingwang, createdTime=Tue Apr 26 11:05:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192388, encodeId=c2821192388e2, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>最近是杂志官网有问题吗？投稿链接进不去呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef215552331, createdName=ms9000001801623307, createdTime=Fri Feb 11 17:08:10 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580933, encodeId=072e580933dc, content=您好，我想问一下您是在哪里看到的投稿要求呢？132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=baef5240403, createdName=147bcb10m39暂无昵称, createdTime=Wed Dec 04 00:00:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091902, encodeId=75de109190256, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091901, encodeId=e48d109190174, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-28 Gym璨烨

SCI文章有没有写作模板？

200 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204749, encodeId=0b212204e49e5, content=投稿一天多从submitted 变成under review，目前投稿500出头，从IBD-s-24-670+变成IBD-d-24-520+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4306577087, createdName=ms2000000536781631, createdTime=Wed May 15 03:20:57 CST 2024, time=2024-05-15, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2123385, encodeId=b4d9212338547, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：2023年1月10投稿，投稿后立马under review，期间就更新过两次状态，最近一次更新是2月15号，到现在一直没有更新，已经快三个样了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Mon Apr 03 10:29:55 CST 2023, time=2023-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1238026, encodeId=fb7612380266a, content=真无语啊，提供的官方链接都是错误的，我死也打不开。 这里才是 https://academic.oup.com/journals/pages/authors, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cee5422993, createdName=ms6000001789977492, createdTime=Thu Aug 11 10:15:49 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232377, encodeId=917512323e787, content=一个半月啦，还在under review，其中under review的时间变了5次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:14:58 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070890, encodeId=fbf510e089010, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：Aug 27 2021 Submitted to journal Aug 30 2021 With Editor Sep 5 2021 With Editor Sep 7 2021 Under Review Sep 13 2021 Under Review Sep 16 2021 Under Review Sep 22 2021 Under Review Sep 22 2021 Under Review Oct 19 2021 Revise Oct 29 2021 Submitted to journal Nov 1 2021 With Editor Nov 2 2021 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8a762575436, createdName=12591279m60暂无昵称, createdTime=Tue Nov 16 21:08:05 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214423, encodeId=02ea121442326, content=审稿速度:3.0 偏重的研究方向：基础;炎症性肠病 经验分享：IBD这个杂志比较坑，最近我们投了一篇，炎症性肠病的基础研究。21年七月份投到，witheditor一个月，under review两个月也就是十月中下旬了，大修返回去又花费了两个月，reviewer满意了回复，然后编辑说图片分辨率不行小修，小修后返回去了，又说语言的问题，历经差不多一年，今年四月份了，以语言的问题拒稿重投，后来又重新投了，10天左右直接拒稿，感觉被杂志耍了，差不多浪费了一年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150810/IMG55C7E7216F9045349.jpg, createdBy=8eec1605831, createdName=shanpingwang, createdTime=Tue Apr 26 11:05:58 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192388, encodeId=c2821192388e2, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>最近是杂志官网有问题吗？投稿链接进不去呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef215552331, createdName=ms9000001801623307, createdTime=Fri Feb 11 17:08:10 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580933, encodeId=072e580933dc, content=您好，我想问一下您是在哪里看到的投稿要求呢？132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 有点时间长了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=baef5240403, createdName=147bcb10m39暂无昵称, createdTime=Wed Dec 04 00:00:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091902, encodeId=75de109190256, content=SCI文章有没有写作模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091901, encodeId=e48d109190174, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-28 桑晒麦拉

为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？

200 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务